| Financial Year |
March 31 2023 |
| Monetary Funds |
2,235,027,082.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
188,907,812.65 |
| Accounts Receivable |
23,716,426,027.04 |
| Advances to Suppliers |
79,241,015.74 |
| Other Receivables |
358,706,000.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,802,126.18 |
| Inventories |
412,421,699.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
278,216,763.38 |
| Total Current Assets |
27,386,191,369.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
318,213,194.40 |
| Investment Properties |
585,696,299.73 |
| Fixed Assetes |
2,132,433,618.97 |
| Under-construction Projects |
243,516,230.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
508,003,987.75 |
| R&D expenses |
13,507,517.52 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,182,783.87 |
| Deferred Income Tax Assets |
197,581,531.28 |
| Other Non-Current Assets |
16,517,519.33 |
| Sub-Total of Non-Current Assets |
5,446,366,749.81 |
| Total Assets |
32,832,558,119.44 |
| Short-Term Loans |
895,716,638.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,538,340,037.89 |
| Accounts Payable |
15,372,371,183.67 |
| Accounts Received In Advance |
1,169,238.26 |
| Employee Compensation Payable |
307,756,711.75 |
| Taxes Payable |
280,843,109.52 |
| Interest Payable |
-- |
| Dividend Payable |
30,817,347.55 |
| Other payables |
459,634,573.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
573,245,255.27 |
| Other Current Liabilities |
355,901,875.81 |
| Sub-Total of Current Liabilities |
20,034,306,802.21 |
| Long-term Loans |
757,644,400.00 |
| Bonds Payable |
699,504,166.73 |
| Long-Term Accounts Payable |
4,705,740.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,367,661.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,448,882,121.42 |
| Total Liabilities |
22,483,188,923.63 |
| Paid-In Capital(Or Share Stock) |
1,262,354,304.00 |
| Capital Surplus |
2,675,285,337.35 |
| Surplus Reserve |
252,375,473.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,582,348,661.55 |
| Minority Stockholder's Interest |
978,389,315.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,370,979,880.56 |
| Owner's Equity（Stockholder's Equity） |
10,349,369,195.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,832,558,119.44 |
